David Margolis
Expertise in
2
conditions

Dr. David Margolis

Infectious Disease
UNC Hospitals Pulmonary Function Lab
101 Manning Dr, 
Chapel Hill, NC 
Expertise in
2
conditions
UNC Hospitals Pulmonary Function Lab
101 Manning Dr, 
Chapel Hill, NC 

Overview

David Margolis is an Infectious Disease provider practicing medicine in Chapel Hill, North Carolina.

Dr. Margolis is highly rated in 2 conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Sepsis, Severe Acute Respiratory Syndrome (SARS), and Myelitis.

He is actively involved in clinical research, co-authoring 239 peer reviewed articles and participating in 5 clinical trials.

Specialties

Infectious Disease

Licenses

Internal Medicine in NC

Hospital Affiliations

Unc Hospitals

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
FirstCarolinaCare
  • HMO
  • MEDICARE MAPD
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Trillium
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

UNC Hospitals Pulmonary Function Lab
101 Manning Dr, Chapel Hill, NC 27514

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

IGHID 11627 - A Phase I Study to Evaluate the Effects of Vorinostat and HIV-1 Antigen Expanded Specific T Cell Therapy (HXTC) on Persistent HIV-1 Infection in HIV-Infected Individuals Started on Antiretroviral Therapy (The XTRA Study)
IGHID 11627 - A Phase I Study to Evaluate the Effects of Vorinostat and HIV-1 Antigen Expanded Specific T Cell Therapy (HXTC) on Persistent HIV-1 Infection in HIV-Infected Individuals Started on Antiretroviral Therapy (The XTRA Study)
Enrollment Status: Completed
Publish Date: May 12, 2023
Intervention Type: Biological, Drug
Study Drugs: Vorinostat, Antigen Expanded Specific T Cell Therapy
Study Phase: Phase 1
A Phase I Pilot Study to Evaluate the Safety and Immunogenicity of the HIV-1 Vaccines MVA.tHIVconsv3 (M3) and MVA.tHIVconsv4 (M4) Given Alone or In Combination in HIV-1-Infected Adults Suppressed on Antiretroviral Therapy - The M&M Study
A Phase I Pilot Study to Evaluate the Safety and Immunogenicity of the HIV-1 Vaccines MVA.tHIVconsv3 (M3) and MVA.tHIVconsv4 (M4) Given Alone or In Combination in HIV-1-Infected Adults Suppressed on Antiretroviral Therapy - The M&M Study
Enrollment Status: Completed
Publish Date: August 09, 2022
Intervention Type: Other, Biological
Study Drugs: MVA.tHIVconsv3, MVA.tHIVconsv4
Study Phase: Phase 1
IGHID 12021 - A Randomized, Phase II Study Comparing the Efficacy and Safety of Standard Versus High-Titer Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody Plasma in Hospitalized Patients With COVID-19
IGHID 12021 - A Randomized, Phase II Study Comparing the Efficacy and Safety of Standard Versus High-Titer Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody Plasma in Hospitalized Patients With COVID-19
Enrollment Status: Completed
Publish Date: December 03, 2021
Intervention Type: Biological
Study Drug: Anti-COVID-19 Plasma
Study Phase: Phase 2
IGHID 11802 - Combination Therapy With the Novel Clearance Modality (VRC07-523LS) and the Latency Reversal Agent (Vorinostat) to Reduce the Frequency of Latent, Resting CD4+ T Cell Infection (The VOR-07 Study)
IGHID 11802 - Combination Therapy With the Novel Clearance Modality (VRC07-523LS) and the Latency Reversal Agent (Vorinostat) to Reduce the Frequency of Latent, Resting CD4+ T Cell Infection (The VOR-07 Study)
Enrollment Status: Completed
Publish Date: December 02, 2021
Intervention Type: Drug, Biological
Study Phase: Phase 1
IGHID 11424 - A Pilot Trial of the Effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection (The VOR VAX Study)
IGHID 11424 - A Pilot Trial of the Effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection (The VOR VAX Study)
Enrollment Status: Terminated
Publish Date: October 07, 2019
Intervention Type: Drug, Biological
Study Phase: Phase 1
View 4 Less Clinical Trials

239 Total Publications

Histone decrotonylation plays a distinct role in HIV latency.
Histone decrotonylation plays a distinct role in HIV latency.
Journal: Science advances
Published: April 10, 2026
Similar Doctors
Expertise in
11
conditions
Dr. David Wohl
Infectious Disease
Expertise in
11
conditions
Dr. David Wohl
Infectious Disease

UNC Hospitals Outpatient Center At Eastowne

100 Eastowne Dr, 
Chapel Hill, NC 
 (4.0 miles away)
984-974-7198
Languages Spoken:
English
See accepted insurances

David Wohl is an Infectious Disease provider practicing medicine in Chapel Hill, North Carolina. Dr. Wohl is highly rated in 11 conditions, according to our data. His clinical expertise encompasses HIV/AIDS, COVID-19, Viral Hemorrhagic Fever, and Ebola Virus Disease.

Expertise in
8
conditions
Dr. Joseph Eron
Infectious Disease
Expertise in
8
conditions
Dr. Joseph Eron
Infectious Disease

UNC Hospitals Pulmonary Function Lab

101 Manning Dr, 
Chapel Hill, NC 
 (0.1 miles away)
984-974-7198
Languages Spoken:
English
See accepted insurances

Joseph Eron is an Infectious Disease provider practicing medicine in Chapel Hill, North Carolina. Dr. Eron is highly rated in 8 conditions, according to our data. His clinical expertise encompasses HIV/AIDS, AIDS Dementia Complex, AIDS Dysmorphic Syndrome, Myelitis, and Tissue Biopsy.

Expertise in
12
conditions
Dr. John Crump
Infectious Disease
Expertise in
12
conditions
Dr. John Crump
Infectious Disease

Private Diagnostic Clinic PLLC

2100 Erwin Rd, 
Durham, NC 
 (9.8 miles away)
919-684-8111
Languages Spoken:
English

John Crump is an Infectious Disease provider practicing medicine in Durham, North Carolina. Dr. Crump is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Salmonella Enterocolitis, Typhoid Fever, Leptospirosis, and Sepsis.

Frequently Asked Questions about Dr. David Margolis

How do I make an appointment with Dr. David Margolis?

You can book an appointment with Dr. David Margolis by calling their office at 919-966-7198. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. David Margolis a top-rated expert for HIV/AIDS?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. David Margolis is classified as an Elite expert for HIV/AIDS, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. David Margolis specialize in?

While Dr. David Margolis is a Infectious Disease, they have specific expertise in HIV/AIDS, Sepsis, and Severe Acute Respiratory Syndrome (SARS). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Infectious Disease.

Does Dr. David Margolis participate in research or clinical trials?

Yes. Dr. David Margolis has published 239 articles and abstracts on conditions like HIV/AIDS. You can view a list of Dr. David Margolis's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. David Margolis accept my insurance?

Dr. David Margolis accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 919-966-7198 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Margolis's expertise for a condition
ConditionClose
    View All 8 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile